A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, B, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A,Language:
english
Pages:
1
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6602172
Date:
September, 2004
File:
PDF, 123 KB
english, 2004
File converter
More search results
More benefits 
